Thanks for highlighting the statistical analysis plan. It never hurts to confirm and verify again. The SAP was approved by the regulators. Ashkan is a careful and precise brain surgeon too!
Dr. Ashkan said this in June 2022. Skip to timestamp 14:55 of the ASCO video.
Dr. Ashkan was the chief investigator of the murcidencel trial for patients in Europe. At King’s College in London, Ashkan is the lead clinician for neuro-oncology and the chair of the King’s Neurosciences Clinical Trial Unit. He is a world-renowned cancer trial expert. A few years ago, Professor Ashkan was named the UK Clinician of the Year by The Brain Tumour Charity. Additionally, Ashkan serves as an advisor to the U.K. government.